Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — April 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.0:1
Daily Buy & Sell Volume

MESOBLAST LTD (MESO)

George Gregory — Director
Apr 10, 2026
Purchase
Shares
2,324,072
Price
$1.48
Total Value
$3.44M
Shares Held After
8,324,072
% of Holdings
27.9%
Apr 10, 2026
Purchase
Shares
10,000
Price
$4.89
Total Value
$48.95K
Shares Held After
3,042,000
% of Holdings
0.3%

MESOBLAST LTD (MESO)

George Gregory — Director
Apr 9, 2026
Purchase
Shares
886,890
Price
$1.43
Total Value
$1.27M
Shares Held After
12,886,890
% of Holdings
6.9%
Apr 9, 2026
Purchase
Shares
5,000
Price
$5.19
Total Value
$25.95K
Shares Held After
3,032,000
% of Holdings
0.2%
Apr 8, 2026
Purchase
Shares
10,000
Price
$5.61
Total Value
$56.05K
Shares Held After
3,027,000
% of Holdings
0.3%

Lipocine Inc. (LPCN)

Higuchi John W. — Director
Apr 7, 2026
Purchase
Shares
40,000
Price
$2.03
Total Value
$81.20K
Shares Held After
203,797
% of Holdings
19.6%
Apr 6, 2026
Purchase
Shares
5,000
Price
$6.32
Total Value
$31.60K
Shares Held After
3,017,000
% of Holdings
0.2%

Lipocine Inc. (LPCN)

Higuchi John W. — Director
Apr 6, 2026
Purchase
Shares
123,000
Price
$2.05
Total Value
$252.15K
Shares Held After
163,797
% of Holdings
75.1%

Lipocine Inc. (LPCN)

Patel Mahesh V. — Director
Apr 6, 2026
Purchase
Shares
25,000
Price
$2.03
Total Value
$50.75K
Shares Held After
160,679
% of Holdings
15.6%

Altimmune, Inc. (ALT)

GILL JOHN — Director
Apr 6, 2026
Purchase
Shares
9,200
Price
$3.41
Total Value
$31.35K
Shares Held After
21,700
% of Holdings
42.4%

MESOBLAST LTD (MESO)

George Gregory — Director
Apr 4, 2026
Purchase
Shares
4,000,000
Price
$1.42
Total Value
$5.68M
Shares Held After
12,000,000
% of Holdings
33.3%
Apr 2, 2026
Purchase
Shares
20,000
Price
$6.09
Total Value
$121.80K
Shares Held After
3,012,000
% of Holdings
0.7%
Apr 2, 2026
Purchase
Shares
713,800
Price
$2.10
Total Value
$1.50M
Shares Held After
3,288,539
% of Holdings
21.7%

Lipocine Inc. (LPCN)

Patel Mahesh V. — Director
Apr 2, 2026
Purchase
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%

Neuraxis, INC (NRXS)

Henrichs Timothy Robert — Chief Financial Officer
Apr 1, 2026
Purchase
Shares
7,593
Price
$1.96
Total Value
$14.88K
Shares Held After
7,593
% of Holdings
100.0%

Neuraxis, INC (NRXS)

Carrico Thomas Joeseph — CRO, CCO, CPO
Apr 1, 2026
Purchase
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
Apr 1, 2026
Purchase
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
Apr 1, 2026
Purchase
Shares
15,000
Price
$3.14
Total Value
$47.10K
Shares Held After
47,500
% of Holdings
31.6%

Altimmune, Inc. (ALT)

WEAVER GREGORY L — Chief Financial Officer
Apr 1, 2026
Purchase
Shares
10,000
Price
$3.15
Total Value
$31.50K
Shares Held After
38,078
% of Holdings
26.3%
Version: v26.3.33